Oxford BioMedica plc Share Price London S.E.
Equities
GB0006648157_GB
GB0006648157
Biotechnology & Medical Research
Sales 2023 | 8.95Cr 11Cr 946.59Cr | Sales 2024 * | 13Cr 16Cr 1.37TCr | Capitalization | 32Cr 41Cr 3.38TCr |
---|---|---|---|---|---|
Net income 2023 | -16Cr -20Cr -1.66TCr | Net income 2024 * | -3.6Cr -4.57Cr -380.59Cr | EV / Sales 2023 | 2.38 x |
Net cash position 2023 * | 4.92Cr 6.24Cr 520.42Cr | Net cash position 2024 * | 1.59Cr 2.01Cr 167.67Cr | EV / Sales 2024 * | 2.35 x |
P/E ratio 2023 |
-1.35
x | P/E ratio 2024 * |
-8.95
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 80.81% |
Latest transcript on Oxford BioMedica plc
Managers | Title | Age | Since |
---|---|---|---|
Frank Mathias
CEO | Chief Executive Officer | 62 | 27/23/27 |
Stuart Paynter
DFI | Director of Finance/CFO | 52 | 29/17/29 |
Chairman | 68 | 24/20/24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leone Patterson
BRD | Director/Board Member | 61 | 01/23/01 |
Chairman | 68 | 24/20/24 | |
Stuart Henderson
BRD | Director/Board Member | 66 | 01/16/01 |
1st Jan change | Capi. | |
---|---|---|
+7.50% | 11TCr | |
+11.44% | 11TCr | |
-12.65% | 2.22TCr | |
+0.44% | 2.13TCr | |
-4.18% | 1.9TCr | |
-37.85% | 1.85TCr | |
-8.69% | 1.68TCr | |
+37.38% | 1.25TCr | |
-23.80% | 808.97Cr |